Companies: 10,795·Total market cap: $144.5T
Compugen Ltd.

Compugen Ltd.

CGENNASDAQHealthcare● Active
$2.04
$-0.07(-3.10%)
Market Cap$192415762
P/E Ratio
52W High$3.24
52W Low$1.3

Compugen Ltd. (CGEN) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

cgen · stock forecast · 14 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 14 Wall Street analysts in the past 3 months

SellBuy

Buy

14 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
13
Hold
0
Sell
1
Strong Sell
0
Total: 14 · Buy rate: 92.9%

12-Month Price Target

High

$5.00

Consensus

$4.50

+120.6% upside

Low

$4.00

Median: $4.5 · Last Close: $2.04

The Compugen Ltd. (CGEN) analyst consensus is Buy, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month CGEN price target is $4.50, representing +120.6% upside from the current price of $2.04.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $5 (120.6%)

Consensus Target

$4.50

120.6% upside

High Target

$5

145.1%

Low Target

$4

96.1%

Current Price

$2.04

as of today

Based on analyst price targets, the CGEN stock price prediction for the next 12 months ranges from $4 to $5. The consensus CGEN price forecast of $4.50 implies 120.6% upside from the current price of $2.04.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$1.945.00%

1-day model range: $1.92–$1.95. Peak: $1.95 (-5.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$1-40.0%
2028$1-52.0%
2029$1-56.8%
2030$1-58.9%
2031-60.0%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

14%0%86%
2Buy
0Neutral
12Sell
RSI (14)23.0Oversold
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · CGEN · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$2.16SELL
MA 10$2.41SELL
MA 20$2.61SELL
MA 50$2.62SELL
MA 100$2.29SELL
MA 200$1.94BUY
Current $CGEN · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$2.19SELL
EMA 10$2.34SELL
EMA 20$2.49SELL
EMA 50$2.51SELL
EMA 100$2.34SELL
EMA 200$2.10SELL
Current $CGEN · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Leerink Partners2026-05-21
Maintains
OutperformOutperform
Truist Securities2024-05-21
Maintains
BuyBuy
Truist Securities2024-03-08
Maintains
BuyBuy
Stifel2023-12-19
Maintains
BuyBuy
Truist Securities2023-08-23
Maintains
BuyBuy
EF Hutton2023-08-07
Maintains
BuyBuy
EF Hutton2023-06-06
Maintains
BuyBuy
EF Hutton2023-05-26
Maintains
BuyBuy
EF Hutton2023-05-24
Maintains
BuyBuy
Oppenheimer2023-05-16
Maintains
OutperformOutperform

Wall Street analysts have recently issued updated ratings on Compugen Ltd. (CGEN) stock. Of the recent 36 rating actions, 0 were upgrades and 2 were downgrades. 14 analysts currently cover CGEN.

Analyst Recommendation Trends

Buy ratings11
Hold ratings00
Sell ratings00

CGEN analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$9M

↓ 69.5% YoY

Revenue Next Year

$16M

↑ 70.5% YoY

EPS This Year

$-0.29

EPS Next Year

$-0.29

↓ 1.8% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast CGEN EPS of $-0.29 for the current fiscal year, based on estimates from 3 analysts. The CGEN revenue forecast is $9M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The CGEN stock forecast is supported by two independent data sources: analyst consensus ratings from 14 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CGEN price target is $4.50 (+120.6% upside), with an analyst consensus of Buy.

The CGEN short-term stock prediction for tomorrow is $1.94 (-5.00%). The CGEN stock price prediction for 2027 estimates an average of $1. The CGEN stock prediction for 2030 projects a range of $1–$1.

Compugen Ltd. trades on NASDAQ under the ticker CGEN. The CGEN stock outlook for 2027 is broadly positive, supported by a Buy consensus among 93% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

CGEN forecast · 8 questions

According to 14 Wall Street analysts, the average 12-month CGEN price target is $4.50, with a high forecast of $5.00 and a low of $4.00. The median price target is shown in the chart above when available. This implies +120.6% potential upside from the current price of $2.04.

CGEN price targetWhat is CGEN price targetCGEN analyst price targetCGEN 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.